On field immunization with a novel influenza vaccine administered via intradermic route (Intanza): tolerability, safety, immunogenicity and acceptability study in subjects ≥ 60 years and evaluation of the compliance with its administration within the physicians.
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2012
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 25 Oct 2012 New trial record